Kurt Bieler

Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.

M. Graf, R. Wagner, K. Uberla, 2000, Human gene therapy.

Concerted Action of Multiple cis-Acting Sequences Is Required for Rev Dependence of Late Human Immunodeficiency Virus Type 1 Gene Expression

M. Graf, R. Wagner, L. Deml, 2000, Journal of Virology.

Capsid stability and replication of human immunodeficiency virus type 1 are influenced critically by charge and size of Gag residue 183.

R. Wagner, C. Ludwig, K. Bieler, 2007, The Journal of general virology.

Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.

R. Wagner, C. Paulus, H. Wolf, 2000, Virology.

Preclinical evaluation of the immunogenicity of C-type HIV-1-based DNA and NYVAC vaccines in the Balb/C mouse model.

R. Wagner, J. Köstler, S. Vieira, 2009, Viral immunology.

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.

G. Pantaleo, R. Wagner, P. Liljeström, 2007, Vaccine.